Percutaneous valve-in-valve implantation using an inverted aortic valve is feasible for treating a dysfunctional tricuspid bioprosthesis in a pediatric patient, potentially postponing surgical replacement.
We report a successful percutaneous revalvulation of a dysfunctional tricuspid bioprothesis in an 8-year-old child. Five years after implanting a 25-mm Carpentier-Edwards valve in the tricuspid position, the prosthesis showed significant dysfunction with clinical right heart failure. A 26-mm Edwards-Sapien XT inverted aortic valve was successfully implanted through a 19F sheath using a jugular approach. Such procedure can significantly postpone the need for surgical replacement of a biological valve.
Gewillig et al. (Tue,) studied this question.